Healthcare Value Capital’s Albany Molecular Research Inc AMRI Stock Holding History

Healthcare Value Capital’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-302,400	Closed	-$4.24M	–	22
2017 Q1	$4.24M	Hold	302,400	–	–	7.26%	6
2016 Q4	$5.67M	Hold	302,400	–	–	6.08%	6
2016 Q3	$4.99M	Hold	302,400	–	–	7.91%	5
2016 Q2	$4.06M	Sell	302,400 -100,000	-25%	-$1.46M	4.93%	7
2016 Q1	$6.15M	Hold	402,400	–	–	9.04%	2
2015 Q4	$7.99M	Hold	402,400	–	–	13.21%	2
2015 Q3	$7.01M	Sell	402,400 -165,000	-29%	-$3.36M	10%	2
2015 Q2	$11.5M	Buy	567,400 +25,000	+5%	+$482K	12.05%	1
2015 Q1	$9.55M	Sell	542,400 -55,800	-9%	-$951K	10.4%	2
2014 Q4	$9.74M	Buy	598,200 +100,000	+20%	+$1.84M	17.8%	1
2014 Q3	$11M	Hold	498,200	–	–	10.61%	2
2014 Q2	$10M	Buy	498,200 +50,000	+11%	+$847K	8.41%	4
2014 Q1	$8.33M	Buy	+448,200	New	+$6.17M	5.45%	4

Other funds holding AMRI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Healthcare Value Capital's AMRI Position: Q2 2017 in Review

Healthcare Value Capital sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 302,400 shares — an estimated $4.24M sold.

Healthcare Value Capital first reported a position in AMRI in Q1 2014 and held it in 13 quarters. The position peaked at $11.5M in Q2 2015. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

Healthcare Value Capital reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
Healthcare Value Capital sold 302,400 Albany Molecular Research Inc shares in Q2 2017, an estimated $4.24M.
Healthcare Value Capital first reported a position in Albany Molecular Research Inc in Q1 2014 and held it in 13 quarters.
Healthcare Value Capital's Albany Molecular Research Inc position peaked at $11.5M in Q2 2015.
136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on Healthcare Value Capital's 13F filing for Q2 2017, filed 10 Aug 2017.